These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 29048655)
1. PomGnT1 enhances temozolomide resistance by activating epithelial-mesenchymal transition signaling in glioblastoma. Liu Q; Xue Y; Chen Q; Chen H; Zhang X; Wang L; Han C; Que S; Lou M; Lan J Oncol Rep; 2017 Nov; 38(5):2911-2918. PubMed ID: 29048655 [TBL] [Abstract][Full Text] [Related]
2. miR‑146b‑5p suppresses glioblastoma cell resistance to temozolomide through targeting TRAF6. Qian Z; Zhou S; Zhou Z; Yang X; Que S; Lan J; Qiu Y; Lin Y Oncol Rep; 2017 Nov; 38(5):2941-2950. PubMed ID: 29048680 [TBL] [Abstract][Full Text] [Related]
3. Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-κB-dependent pathway downregulating MGMT expression. Lan F; Yang Y; Han J; Wu Q; Yu H; Yue X Int J Oncol; 2016 Feb; 48(2):559-68. PubMed ID: 26648123 [TBL] [Abstract][Full Text] [Related]
4. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma. Lan F; Pan Q; Yu H; Yue X J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372 [TBL] [Abstract][Full Text] [Related]
5. FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β-catenin nuclear accumulation. Xu K; Zhang Z; Pei H; Wang H; Li L; Xia Q Oncol Rep; 2017 Apr; 37(4):2391-2397. PubMed ID: 28260024 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT. Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036 [TBL] [Abstract][Full Text] [Related]
7. Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line. Ashizawa T; Akiyama Y; Miyata H; Iizuka A; Komiyama M; Kume A; Omiya M; Sugino T; Asai A; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K Int J Oncol; 2014 Jul; 45(1):411-8. PubMed ID: 24820265 [TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide. Li H; Yuan X; Yan D; Li D; Guan F; Dong Y; Wang H; Liu X; Yang B Cell Physiol Biochem; 2017; 42(3):1192-1201. PubMed ID: 28668966 [TBL] [Abstract][Full Text] [Related]
9. SPOCK1 is upregulated in recurrent glioblastoma and contributes to metastasis and Temozolomide resistance. Yu F; Li G; Gao J; Sun Y; Liu P; Gao H; Li P; Lei T; Chen Y; Cheng Y; Zhai X; Sayari AJ; Huang H; Mu Q Cell Prolif; 2016 Apr; 49(2):195-206. PubMed ID: 26923184 [TBL] [Abstract][Full Text] [Related]
10. YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line. Akiyama Y; Ashizawa T; Komiyama M; Miyata H; Oshita C; Omiya M; Iizuka A; Kume A; Sugino T; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K Oncol Rep; 2014 Jul; 32(1):159-66. PubMed ID: 24842123 [TBL] [Abstract][Full Text] [Related]
11. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746 [TBL] [Abstract][Full Text] [Related]
12. Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR/Integrin β1/FAK signaling pathway. Zou Y; Xu L; Wang W; Zhu X; Lin J; Li H; Chen J; Xu W; Gao H; Wu X; Yin Z; Wang Q Phytomedicine; 2024 Jul; 129():155714. PubMed ID: 38723526 [TBL] [Abstract][Full Text] [Related]
13. A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme. Kim SS; Rait A; Kim E; Pirollo KF; Chang EH Nanomedicine; 2015 Feb; 11(2):301-11. PubMed ID: 25240597 [TBL] [Abstract][Full Text] [Related]
14. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance. Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522 [TBL] [Abstract][Full Text] [Related]
15. NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition. Tsai CY; Ko HJ; Chiou SJ; Lai YL; Hou CC; Javaria T; Huang ZY; Cheng TS; Hsu TI; Chuang JY; Kwan AL; Chuang TH; Huang CF; Loh JK; Hong YR Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072831 [TBL] [Abstract][Full Text] [Related]
16. Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma. Zhang Z; Yin J; Lu C; Wei Y; Zeng A; You Y J Exp Clin Cancer Res; 2019 Apr; 38(1):166. PubMed ID: 30992025 [TBL] [Abstract][Full Text] [Related]
17. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression. Wei J; Qi X; Zhan Q; Zhou D; Yan Q; Wang Y; Mo L; Wan Y; Xie D; Xie J; Yang S Biomed Pharmacother; 2015 Apr; 71():112-8. PubMed ID: 25960225 [TBL] [Abstract][Full Text] [Related]
18. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway. Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149 [TBL] [Abstract][Full Text] [Related]
19. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2. Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849 [TBL] [Abstract][Full Text] [Related]
20. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis. Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]